特拉维尔治疗 TVTX
$49.60 +$0.73 (+1.49%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $49.00 -1.21%
开盘$49.74
昨收$48.87
当日区间$48.64 – $50.45
成交量1.01M
市值$4.76B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例116.6%+0.81 个百分点，较上季度
持仓机构数408+14 ，较上季度
内部人近期交易18次买入 / 32次卖出净卖出
空头持仓比例11.58% 占流通股回补天数 5.2 · 截至 15 Oct 2026
卖空成交量占比17.6%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$589.5K（13个净流入日，7个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有36.6%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从12.56%降至11.58%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +718,109 | 1.2% |
| Bank of America Corporation | Public Company | 2026/Q3 | +3,257,423 | 4.2% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +1,592,356 | 2.7% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +1,154,671 | 1.4% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +1,047,578 | 1.2% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +974,600 | 2.0% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q3 | +955,114 | 1.0% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +774,071 | 1.5% |
| Rock Springs Capital Management LP | Hedge Fund | 2026/Q3 | +701,115 | 2.3% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +636,419 | 1.0% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +603,925 | 1.5% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +510,808 | 1.6% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +478,860 | 0.5% |
| Graham Capital Management, L.P. | Hedge Fund | 2026/Q3 | +446,696 | 0.5% |
| Kynam Capital Management, LP | Hedge Fund | 2026/Q3 | +430,982 | 2.1% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Oct 2026 | Eric Dube | Chief Executive Officer | Intent to Sell (Form 144) | -243,735 | $53.27 | – |
| 14 Oct 2026 | Eric Dube | Chief Executive Officer | Derivative Exercise and Sale | -243,735 | $55.02 | 152,367 |
| 16 Sep 2026 | Eric Dube | Chief Executive Officer | Intent to Sell (Form 144) | -108,493 | $63.48 | – |
| 16 Sep 2026 | Peter Heerma | Chief Commercial Officer | Intent to Sell (Form 144) | -8,282 | $63.48 | – |
| 16 Sep 2026 | Eric Dube | Chief Executive Officer | Derivative Exercise and Sale | -400,000 | $65.31 | 152,367 |
| 16 Sep 2026 | Peter Heerma | Chief Commercial Officer | Derivative Exercise and Sale | -258,189 | $65.07 | 61,430 |
| 15 Sep 2026 | William Rote | Chief Research Officer | Intent to Sell (Form 144) | -112,850 | $62.51 | – |
| 15 Sep 2026 | Eric Dube | Chief Executive Officer | Intent to Sell (Form 144) | -195,841 | $62.51 | – |
| 15 Sep 2026 | Peter Heerma | Chief Commercial Officer | Intent to Sell (Form 144) | -172,717 | $62.51 | – |
| 14 Sep 2026 | Elizabeth Reed | Chief Legal Officer, General Counsel & Secretary | Derivative Exercise and Sale | -37,500 | $65.31 | 105,389 |
| 14 Sep 2026 | William Rote | Chief Research Officer | Intent to Sell (Form 144) | -96,198 | $65.79 | – |
| 14 Sep 2026 | Christopher Cline | Chief Financial Officer | Automatic Disposition | -30,508 | $65.31 | 87,508 |
| 14 Sep 2026 | Christopher Cline | Chief Financial Officer | Derivative Exercise and Sale | -20,000 | $62.00 | 87,508 |
| 14 Sep 2026 | Eric Dube | Chief Executive Officer | Intent to Sell (Form 144) | -95,666 | $65.79 | – |
| 14 Sep 2026 | Peter Heerma | Chief Commercial Officer | Automatic Disposition | -25,000 | $65.31 | 61,430 |
| 14 Sep 2026 | Sandra Calvin | SVP & Chief Accounting Officer | Derivative Exercise and Sale | -5,375 | $63.66 | 42,353 |
| 14 Sep 2026 | Jula Inrig | Executive VP, Head of Research & Development and Chief Medical Officer | Automatic Disposition | -12,279 | $65.31 | 100,491 |
| 14 Sep 2026 | Jula Inrig | Executive VP, Head of Research & Development and Chief Medical Officer | Derivative Exercise and Sale | -32,395 | $62.62 | 100,491 |
| 9 Sep 2026 | Jeffrey Meckler | Independent Director | Derivative Exercise and Sale | -20,000 | $68.09 | 91,500 |
| 1 Sep 2026 | Christopher Cline | Chief Financial Officer | Open Market Disposition | -642 | $66.37 | 118,016 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 10,913,583 | 11.6% | 5.2 |
| 30 Sep 2026 | 12,655,839 | 13.4% | 7.2 |
| 15 Sep 2026 | 12,955,933 | 13.7% | 10.4 |
| 31 Aug 2026 | 12,004,820 | 12.7% | 9.6 |
| 14 Aug 2026 | 11,943,638 | 12.7% | 5.7 |
| 31 Jul 2026 | 11,676,586 | 12.6% | 9.4 |
暂无评论——快来第一个聊聊 TVTX。
登录后参与讨论。